China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

The market is poised to experience significant growth throughout the forecast period from 2024 to 2032. In 2024, the market exhibited steady growth, and with the implementation of strategic ...

However, 10 companies defied a broader market optimism, mostly due to a series of stock rating downgrades from investment ...

We recently compiled a list of the These 10 Firms Were Last Week’s Worst Performers. In this article, we are going to take a ...

For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...